These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28826564)

  • 21. Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Schmidt N; Schmidt B; Dressel A; Gergei I; Klotsche J; Pieper L; Scharnagl H; Kleber ME; März W; Lehnert H; Pittrow D; Stalla G; Wittchen HU; Grammer TB
    Atherosclerosis; 2017 Nov; 266():24-30. PubMed ID: 28946037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of familial hypercholesterolemia phenotype and ten-year risk of cardiovascular events in a working population in primary prevention: The ICARIA study.
    Sánchez-Ramos A; Fernández-Labandera C; Vallejo-Vaz AJ; Bonacho EC; Quevedo-Aguado L; Catalina-Romero C; Valdivielso P; Sánchez-Chaparro MÁ
    Atherosclerosis; 2021 Dec; 338():39-45. PubMed ID: 34785430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The frequency of familial hypercholesterolemia amongst patients in the outpatient clinic of the tertiary specialized cardiology center in Kyrgyzstan.
    Lunegova OS; Mirrakhimov AE; Hodzhiboboev E; Bektasheva EE; Neronova KV; Toktomamatov UM; Zakirov U; Asanbaev A; Arapova RA; Abilova SS; Kerimkulova AS; Mirrakhimov EM
    Atheroscler Suppl; 2019 Mar; 36():1-5. PubMed ID: 30876526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.
    Nenseter MS; Lindvig HW; Ueland T; Langslet G; Ose L; Holven KB; Retterstøl K
    Atherosclerosis; 2011 Jun; 216(2):426-32. PubMed ID: 21376325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Treatment of Familial Hypercholesterolemia in France.
    Bérard E; Bongard V; Haas B; Dallongeville J; Moitry M; Cottel D; Ruidavets JB; Ferrières J
    Can J Cardiol; 2019 Jun; 35(6):744-752. PubMed ID: 31151710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India.
    Sawhney JPS; Prasad SR; Sharma M; Madan K; Mohanty A; Passey R; Mehta A; Kandpal B; Makhija A; Jain R; Mantri RR; Vivek BS; Manchanda SC; Verma IC
    Indian Heart J; 2019; 71(2):118-122. PubMed ID: 31280822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
    Abul-Husn NS; Manickam K; Jones LK; Wright EA; Hartzel DN; Gonzaga-Jauregui C; O'Dushlaine C; Leader JB; Lester Kirchner H; Lindbuchler DM; Barr ML; Giovanni MA; Ritchie MD; Overton JD; Reid JG; Metpally RP; Wardeh AH; Borecki IB; Yancopoulos GD; Baras A; Shuldiner AR; Gottesman O; Ledbetter DH; Carey DJ; Dewey FE; Murray MF
    Science; 2016 Dec; 354(6319):. PubMed ID: 28008010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
    Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology.
    De Backer G; Besseling J; Chapman J; Hovingh GK; Kastelein JJ; Kotseva K; Ray K; Reiner Ž; Wood D; De Bacquer D;
    Atherosclerosis; 2015 Jul; 241(1):169-75. PubMed ID: 25997074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
    Elis A; Zhou R; Stein EA
    Am J Cardiol; 2011 Jul; 108(2):223-6. PubMed ID: 21545982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study.
    Casula M; Gazzotti M; Capra ME; Olmastroni E; Galimberti F; Catapano AL; Pederiva C;
    Atherosclerosis; 2023 Nov; 385():117231. PubMed ID: 37648636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.
    Ten Kate GR; Bos S; Dedic A; Neefjes LA; Kurata A; Langendonk JG; Liem A; Moelker A; Krestin GP; de Feyter PJ; Roeters van Lennep JE; Nieman K; Sijbrands EJ
    J Am Coll Cardiol; 2015 Dec; 66(24):2687-2695. PubMed ID: 26700830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence and related factors of familial hypercholesterolemia in rural population of China using Chinese modified Dutch Lipid Clinic Network definition.
    Wang Y; Li Y; Liu X; Tu R; Zhang H; Qian X; Jiang J; Qiao D; Liu X; Luo Z; Dong X; Wang C
    BMC Public Health; 2019 Jun; 19(1):837. PubMed ID: 31248412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
    Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
    Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hypercholesterolemia and atherosclerotic cardiovascular mortality among Korean adults with low levels of serum cholesterol.
    Jung KJ; Koh H; Choi Y; Lee SJ; Ji E; Jee SH
    Atherosclerosis; 2018 Nov; 278():103-109. PubMed ID: 30261470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Bernard S; Ruel I; Blank DW; Genest J; Baass A
    J Clin Lipidol; 2019; 13(1):123-128. PubMed ID: 30318454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.